Pepti review: $99 semaglutide, one open question

Pepti (hellopepti.com) sells 68 prescription products and prices the headline one at $99 a month. That is among the lowest semaglutide rates this desk has verified from a provider's own data rather than its marketing copy. It also carries a contradiction we could not resolve, and the honest way to publish the number is with the contradiction attached to it.

The price, as the site renders it

Injectable semaglutide is $99 a month. Injectable tirzepatide is $199. Both are flat: the same figure at every titration dose, which the site states explicitly on its cost pages and repeats on three cross-sell surfaces. A one-time purchase instead of a subscription costs 1.25 times the monthly rate — $124 and $249 — and that multiplier holds across the catalog, which is a good sign that the price object is real data rather than hand-typed copy. Cancellation is any time, effective at the end of the cycle, with a pause of up to 90 days available.¹

Elsewhere on the shelf: oral semaglutide $249 a month, oral tirzepatide $399, GLP-1 oral drops $239, two named low-dose "longevity microdose" products at $149 and $229, BPC-157 $209, NAD+ $159 to $219 across capsule, injection and nasal, sermorelin and tesamorelin $189 each, DSIP $189, PT-141 $189 to $199, and a $199 at-home hormone or metabolic blood panel. There is no membership fee layered on top of any of it.

The open question: a price ladder nothing renders

Pepti's server payload for its semaglutide and tirzepatide pages carries a per-dose price array — semaglutide at $299, $349, $399 and $449 by dose, tirzepatide at $349, $399, $449 and $549 — sitting in production data on the same site whose cost page says one flat price at every dose. We downloaded every client bundle the pages load. Not one of them reads that array. It renders nowhere, no control exposes it, and nothing in the purchase flow references it.

So there are two numbers in Pepti's own production data and they differ by roughly three times. We trusted the $99 and $199, because that is what the page shows, what the catalog object carries, and what the cost page and three other surfaces repeat. But we could not break the tie at a checkout: the site's checkout endpoint accepts POST only and returns a 405 to anything else, so there is no way to see a real charge without submitting an intake. Until somebody walks that intake to a card form, this stays open. If you sign up with Pepti, the thing worth screenshotting is the confirmation page.

Neither reading is an accusation. A stale array left behind by a pricing change is the boring explanation and probably the right one. But a dormant ladder averaging three times the headline is exactly the shape of the step-up we warn readers about, and we are not going to file $99 as settled fact while it sits there.

Thirty-six states, or fifty

Pepti publishes a list of 36 states it ships to, on four separate pages plus its own homepage title. Its terms of service say the service is available in 50. The 36-state list is corroborated four ways and names the states; the terms line names none, so we treat 36 as operative and the terms sentence as the outlier. At-home blood testing does ship to all 50. If your state matters to your shortlist — and it usually does — check the shipping page, not the terms.

When you are actually charged

Same pattern, second contradiction. The how-it-works page says you pay nothing until a physician approves your treatment. The refund policy says payment is collected at checkout, before a licensed provider reviews your intake. Those cannot both be true. The refund policy is the operative document, so plan on being charged first and refunded — in five to ten business days, per the policy — if you are declined. Once medication ships there are no refunds, and canceling mid-cycle is not pro-rated.

What is on the shelf that should not be on your list

Pepti's catalog runs deep, and part of it is not shoppable in any responsible sense. It sells retatrutide at $399 a month — a molecule with no marketing approval in any jurisdiction, which we cover in what the retatrutide trial data actually shows. It also sells melanotan II and IGF-1 LR3. This desk does not treat any of those three as recommendable products, at any price, and their presence is a mark against a catalog that is otherwise built out of ordinary compounded and generic medicine.

The flip side is that Pepti carries the only genuine sleep peptide in this batch of seven — DSIP at $189 a month, plus a DSIP, BPC-157 and CJC-1295 stack at $239 — and the deepest nootropic line, with semax, selank, synapsin and methylene blue all priced.

Who is behind it, and who is not named

Two prescribers are named with full bios: Dr. Gene Lee, MD, the medical director, board-certified in family medicine and licensed in 26 listed states, and Dr. Laeeq Butt, MD MBA, the chief medical officer, internal medicine, licensed in 15. Neither publishes an NPI, so neither can be checked against the federal registry the way we checked The Edit's medical director. The pharmacy is never named at all — described only as "independent FDA-registered 503A or 503B compounding pharmacies". That is the single biggest disclosure gap here, and it is the one our provider checklist treats as a yellow flag. The corporate entity is pepti LLC, registered at a Newark, Delaware address widely used as a registered-agent suite rather than an operating site. Its LegitScript seal resolves to a real certification record.

The regulatory screen

The trading name and the legal entity both returned zero company-column matches in the FDA's live warning-letter index in August 2026, and the pass carried a positive control that returned a known February 2026 letter for an unrelated telehealth seller every time.² Worth noting what the search around it looked like: querying the word "pepti" returns 45 warning letters, and several of them are peptide sellers. Pepti LLC is not among them.

Where it lands

At $99 and $199 with a genuinely flat dose ladder and no membership fee, Pepti is the cheapest verified rate in this batch by a wide margin — cheaper than Trellis at $150, Auren Rx at $199 and The Edit at $209. If that number holds at checkout, it belongs near the top of a cheapest-semaglutide read. We would want the dormant ladder resolved and the pharmacy named before we called it settled, and we would want you charged after a clinician reads your intake rather than before. Nothing about that is disqualifying. All of it is worth knowing before you enter a card.